Skip to main content

Delphine Kervella

Institutions of which they are part

Postdoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Delphine Kervella

Institutions of which they are part

Postdoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Projects

Caracterización de la respuesta inmune celular específica frente al virus Epstein-Barr en receptores de trasplante renal pediátrico (CRICE-VEB)).

IP: -
Collaborators: Gema Ariceta Iraola, Laura Donadeu Casassas, Delphine Kervella
Funding agency: Sociedad Española de Trasplantes
Funding: 20000
Reference: SET/AYUDAS.PROYECTOS/2023/LOPEZ
Duration: 01/01/2024 - 31/12/2025

Duacept, a novel bi-specific fusion protein to prevent transplant rejection

IP: Oriol Bestard Matamoros
Collaborators: Tanit Devant Egea, Delphine Kervella
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 165165
Reference: SLT036/24/000043
Duration: 21/12/2024 - 20/12/2026

RESETTING THE IMMUNOLOGICAL SYSTEM OF HYPERSENSITIZED TRANSPLANT CANDIDATES TO ALLOW ACCESS TO HLA COMPATIBLE KIDNEY TRANSPLANTATION (RESET TRIAL)

IP: Oriol Bestard Matamoros
Collaborators: Ana Pérez González, Franc Casanova Ferrer, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, Clàudia Carrera Muñoz, Maria Antonia Emilia Meneghini, Delphine Kervella
Funding agency: Instituto de Salud Carlos III
Funding: 465456.69
Reference: ICI24/00066
Duration: 01/01/2025 - 31/12/2029

Cambios histológicos y transcripcionales en distintos fenotipos de Rechazo mediado por anticuerpos

IP: Irina Betsabe Torres Rodriguez
Collaborators: Francesc Moreso Mateos, Franc Casanova Ferrer, Nestor Gabriel Toapanta Gaibor, Delphine Kervella
Funding agency: Instituto de Salud Carlos III
Funding: 96250
Reference: PI23/01909
Duration: 01/01/2024 - 31/12/2026

Related news

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

Related professionals

Teresa Crespo Rivero

Teresa Crespo Rivero

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Pau Tomàs  Fernàndez

Pau Tomàs Fernàndez

Predoctoral researcher
Biomedical Research in Gynaecology
Read more
Alan Muñoz Soler

Alan Muñoz Soler

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Vanesa Dávalos Yerovi

Vanesa Dávalos Yerovi

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.